These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 21527734)

  • 1. Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions.
    Francis SH; Blount MA; Corbin JD
    Physiol Rev; 2011 Apr; 91(2):651-90. PubMed ID: 21527734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phosphodiesterases of cyclic GMP].
    Wróblewska H; Gorczyca WA
    Postepy Hig Med Dosw; 2001; 55(5):611-27. PubMed ID: 11795198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic nucleotide phosphodiesterases: relating structure and function.
    Francis SH; Turko IV; Corbin JD
    Prog Nucleic Acid Res Mol Biol; 2001; 65():1-52. PubMed ID: 11008484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
    Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
    Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
    Torphy TJ; Cieslinski LB
    Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of PDE4 structure on inhibitor selectivity across PDE families.
    Ke H
    Int J Impot Res; 2004 Jun; 16 Suppl 1():S24-7. PubMed ID: 15224132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
    Torphy TJ; Zhou HL; Burman M; Huang LB
    Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterases in neurodegenerative disorders.
    Bollen E; Prickaerts J
    IUBMB Life; 2012 Dec; 64(12):965-70. PubMed ID: 23129425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
    de Vente J; Markerink-van Ittersum M; Vles JS
    J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases.
    Zhang KY; Card GL; Suzuki Y; Artis DR; Fong D; Gillette S; Hsieh D; Neiman J; West BL; Zhang C; Milburn MV; Kim SH; Schlessinger J; Bollag G
    Mol Cell; 2004 Jul; 15(2):279-86. PubMed ID: 15260978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1).
    Kakkar R; Raju RV; Sharma RK
    Cell Mol Life Sci; 1999 Jul; 55(8-9):1164-86. PubMed ID: 10442095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the study of Ca2+/CaM-activated phosphodiesterases: expression and physiological functions.
    Zhao AZ; Yan C; Sonnenburg WK; Beavo JA
    Adv Second Messenger Phosphoprotein Res; 1997; 31():237-51. PubMed ID: 9344255
    [No Abstract]   [Full Text] [Related]  

  • 13. Diversity in cyclic nucleotide phosphodiesterase isoenzyme families.
    Manganiello VC; Murata T; Taira M; Belfrage P; Degerman E
    Arch Biochem Biophys; 1995 Sep; 322(1):1-13. PubMed ID: 7574662
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.
    Ahmad F; Murata T; Shimizu K; Degerman E; Maurice D; Manganiello V
    Oral Dis; 2015 Jan; 21(1):e25-50. PubMed ID: 25056711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time monitoring of phosphodiesterase inhibition in intact cells.
    Herget S; Lohse MJ; Nikolaev VO
    Cell Signal; 2008 Aug; 20(8):1423-31. PubMed ID: 18467075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium.
    Bode DC; Hamel LT; Wax MB
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1286-91. PubMed ID: 8263791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of human phosphodiesterase 3B: atomic basis for substrate and inhibitor specificity.
    Scapin G; Patel SB; Chung C; Varnerin JP; Edmondson SD; Mastracchio A; Parmee ER; Singh SB; Becker JW; Van der Ploeg LH; Tota MR
    Biochemistry; 2004 May; 43(20):6091-100. PubMed ID: 15147193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.
    Netherton SJ; Maurice DH
    Mol Pharmacol; 2005 Jan; 67(1):263-72. PubMed ID: 15475573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a novel cAMP-binding, cAMP-specific cyclic nucleotide phosphodiesterase (TcrPDEB1) from Trypanosoma cruzi.
    Díaz-Benjumea R; Laxman S; Hinds TR; Beavo JA; Rascón A
    Biochem J; 2006 Oct; 399(2):305-14. PubMed ID: 16776650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.